Company
Headquarters: Beijing, China
Employees: 748
CEO: Ms. Yue'e Zhang
HK$1.96 Billion
HKD as of Jan. 1, 2026
US$251.8 Million
| Company | Market Cap (USD) |
|---|---|
| Intuitive | $201.46 B |
| EssilorLuxottica SA | $144.43 B |
| Becton, Dickinson and Company | $55.63 B |
| HOYA Corp | $50.63 B |
| Alcon Inc. | $39.46 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
PW Medtech Group Limited, an investment holding company, operates as a medical device company in the People's Republic of China. It manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light resistant infusion sets, and intravenous cannula products, as well as human plasma-based biopharmaceutical products. The company was formerly known as Pyholding Limited. PW Medtech Group Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
PW Medtech Group Ltd has the following listings and related stock indices.
Stock: HKEX: 1358
Stock: FSX: PWE